f-18-psma-1007
Recombinant proteinexperimentalImaging agent
Clinical trial activity
13 trials · 15 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
8
Phase 3
5
Phase 4
0
Earliest trial started Mar 6, 2019 (NCT04102553)
Timeline
Indications
Mechanism of action
- Glutamate carboxypeptidase IIINHIBITOR
FOLH1 inhibitor
Chemistry & pharmacology
- Multi-specific
- No
- Imaging
- 18-fluorine
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06881823 | Phase 1/Phase 2 (Phase 2) | Jun 29, 2026 | Novartis |
| NCT06565247 | Phase 3 | Aug 31, 2024 | Lund University, Region Skane, Umea University, Västerbotten County Council |
| NCT06462495 | Early Phase 1 (Phase 1) | Apr 10, 2024 | Anhui Medical University, Anhui Province Cancer Hospital |
| NCT06122584 | Phase 3 | Jan 31, 2024 | ABX advanced biochemical compounds GmbH |
| NCT06723665 | N/A | Jan 25, 2024 | Jiangnan University |
| NCT05712174 | Phase 2 | Sep 7, 2023 | University of Alberta, University of Calgary |
| NCT05815316 | Phase 2 | Apr 30, 2023 | Vita-Salute University of Milano. Italy |
| NCT05520255 | Phase 3 | Jan 31, 2023 | University of Alberta |
| NCT05534594 | N/A | Aug 19, 2022 | University of Groningen |
| NCT05448404 | N/A | Mar 8, 2022 | China Medical University |
| NCT04742361 | Phase 3 | Sep 8, 2021 | ABX advanced biochemical compounds GmbH |
| NCT04588454 | N/A | Jan 17, 2020 | Radboud University |
| NCT04102553 | Phase 3 | Mar 6, 2019 | ABX advanced biochemical compounds GmbH |
Showing 13 of 13 trials
Page 1 / 1
Organizations
Research & Development (15)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| ABX advanced biochemical compounds GmbH | For profit | 3 | 3 | 1 | 2019 |
| University of Alberta | Academic/Hospital | 2 | 1 | 2 | 2023 |
| Anhui Medical University | Academic/Hospital | 1 | 1 | 1 | 2024 |
| Anhui Province Cancer Hospital | Academic/Hospital | 1 | 0 | 1 | 2024 |
| China Medical University | Academic/Hospital | 1 | 1 | 1 | 2022 |
| Jiangnan University | Academic/Hospital | 1 | 1 | 1 | 2024 |
| Lund University | Academic/Hospital | 1 | 0 | 1 | 2024 |
| Novartis | For profit | 1 | 1 | 1 | 2026 |
| Radboud University | Academic/Hospital | 1 | 1 | 1 | 2020 |
| Region Skane | Government | 1 | 0 | 1 | 2024 |
| Umea University | Academic/Hospital | 1 | 0 | 1 | 2024 |
| University of Calgary | Academic/Hospital | 1 | 1 | 1 | 2023 |
| University of Groningen | Academic/Hospital | 1 | 1 | 1 | 2022 |
| Västerbotten County Council | Government | 1 | 1 | 1 | 2024 |
| Vita-Salute University of Milano. Italy | Academic/Hospital | 1 | 1 | 1 | 2023 |
15 organizations
Page 1 / 1